US20010031947A1 - Method and apparatus for drug infusion - Google Patents
Method and apparatus for drug infusion Download PDFInfo
- Publication number
- US20010031947A1 US20010031947A1 US09/416,151 US41615199A US2001031947A1 US 20010031947 A1 US20010031947 A1 US 20010031947A1 US 41615199 A US41615199 A US 41615199A US 2001031947 A1 US2001031947 A1 US 2001031947A1
- Authority
- US
- United States
- Prior art keywords
- fluid reservoir
- displacement means
- reservoir
- drug
- fluid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 114
- 229940079593 drug Drugs 0.000 title claims abstract description 114
- 238000000034 method Methods 0.000 title claims abstract description 11
- 238000001802 infusion Methods 0.000 title claims description 27
- 239000012530 fluid Substances 0.000 claims abstract description 80
- 238000006073 displacement reaction Methods 0.000 claims abstract description 41
- 230000009471 action Effects 0.000 claims description 3
- 239000000463 material Substances 0.000 description 11
- 230000008901 benefit Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000007246 mechanism Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000008177 pharmaceutical agent Substances 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 229910052710 silicon Inorganic materials 0.000 description 2
- 239000010703 silicon Substances 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000008223 sterile water Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011549 displacement method Methods 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 238000005459 micromachining Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 230000009972 noncorrosive effect Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14244—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body
- A61M5/14276—Pressure infusion, e.g. using pumps adapted to be carried by the patient, e.g. portable on the body specially adapted for implantation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M2005/14506—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons mechanically driven, e.g. spring or clockwork
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
- A61M2005/14513—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons with secondary fluid driving or regulating the infusion
Definitions
- the present invention relates generally to a method and apparatus for the delivery of fluids to a desired location within the body; and more particularly, relates to an implantable drug infusion device for delivery of pharmaceutical agents or other fluids directly from a reservoir within the device to a specific desired location within a patient's body.
- Implantable drug infusion devices usually are implanted for several years, during which time there is no opportunity to service or repair these devices. Accordingly, both the implanted device and the drug to be infused must remain operative and be stable for a long period.
- Conventional implantable fluid delivery systems for drug infusion typically include a reservoir to store the fluid, and a separate pump or other flow control device to deliver the fluid.
- This type of implantable drug infusion system is shown generally in FIG. 1.
- Reservoirs in conventional implanted drug infusion devices undergo little motion, so that the materials which form the reservoir can be selected primarily for compatibility with the drug that is to be delivered.
- Pumps typically have many moving parts.
- the materials from which the pumps are made thus must be selected for specific mechanical properties, such as flexibility, durability, and strength.
- the materials used may not exhibit all desirable mechanical properties, or may not be compatible with some drugs to be infused.
- An example is a silicone tube in a peristaltic pump. Silicone is very flexible and durable, but is permeable to many fluids and is not as strong as other elastomers.
- implantable infusion devices preferably are small in size
- the devices typically have only limited internal space, so that any materials used in the manufacture of the device must be of the type that can be used to manufacture very small parts.
- One example of such a material is silicon formed by micromachining. Silicon, however, is difficult to join to other materials.
- a drug or other fluid to be delivered to a specific desired location within the body is stored in a reservoir that is directly displaced by a force to infuse the drug from the device into the patient.
- Several methods can be used to displace the reservoir, which are described in more detail below.
- the present invention is described herein in terms of three presently preferred embodiments which include, generally, hydraulic displacement, mechanical screw-type displacement, and spring force displacement of the fluid reservoir.
- the invention is not limited strictly to the embodiments described herein.
- the first preferred method of displacing the reservoir is hydraulic. See FIGS. 2 and 3.
- the pump does not contact the drug, but recirculates a working fluid inside the device.
- the working fluid can be selected to be non-corrosive, or even to enhance the operation of the pump. Again, the choice of working fluid depends upon the circumstances involved in a particular application. However, examples of working fluids include sterile water, sterile saline, silicone oil, or a lubricant.
- the pump withdraws the working fluid from the bottom reservoir and pumps it into an intermediate reservoir under the drug reservoir.
- the drug and intermediate reservoirs are separated by, for example, a diaphragm (See FIG. 2) or a piston (See FIG. 3).
- a diaphragm See FIG. 2
- a piston See FIG. 3
- the drug and intermediate reservoirs be sealed, so that no fluid may pass from one into the other.
- the drug is forced out of the device.
- the pump is programmable to any pattern or rate utilized in an implantable device.
- the drug infusion will follow the rate or pattern programmed. Examples of program rates and patterns include those commonly used with the SynchroMedTM Programmable Pump, available commercially from Medtronic, Inc., Minneapolis, Minn.
- a means of maintaining constant pressure in the device, such as a volatile fluid, is required under the internal drug reservoir.
- a syringe is introduced into the reservoir via a hypodermic needle.
- the drug exit path is closed and the pump is then reversed to draw the drug from the syringe into the reservoir. This method also eliminates the possibility of forcing the drug into the reservoir with the syringe and damaging the device or over-infusing the drug.
- the internal drug reservoir is directly displaced mechanically, either by a motor and lead screw (See FIG. 4) or a motor and worm gear (See FIG. 5).
- the motor rotates and displaces a nut on the lead screw.
- the nut is attached directly to the reservoir base and directly displaces it as it moves.
- This system is less susceptible to changes in pressure inside the device during operation. However, a volatile fluid still may be used to ensure that a relatively constant internal pressure is maintained.
- the motor may be programmed to any pattern or rate, such as those used in commercially available implantable devices like the SynchroMedTM, and the motor is reversed to refill the drug reservoir.
- This first configuration is most suited for a donut-type bellows to ensure that no contaminant reaches the interior of the drug reservoir.
- a motor rotates a worm gear that displaces a rack coupled to the bottom portion of the drug reservoir.
- a flexible side bellows allows the drug reservoir base to be displaced upwards as the worm gear turns, forcing drug from the reservoir to the desired delivery site.
- the motor may be programmed so that drug is delivered at a desired rate or pattern, and may be reversed to facilitate the refilling of the drug reservoir.
- the side bellows are hermetically sealed to keep the drug free of possible contamination from unwanted sources, and to protect any adverse impact which might result from their contacting the drugs.
- the third embodiment of the present invention utilizes the spring force of the reservoir bellows to displace the drug reservoir.
- the bellows is annealed, so that in its relaxed, natural state it is completely collapsed.
- the bellows is expanded by a device such as a motor which turns a flywheel or pulley to wind one end of a cable about the pulley or flywheel, the other end of the cable being connected to the bottom of the drug reservoir.
- the pulley/cable is relaxed to allow the bellows to return to its natural, collapsed state.
- the motor may be programmed to any pattern or rate to ensure that the displaced drug is delivered according to the desired schedule, and the motor may be programmed to allow for controlled refilling.
- the drug contacts only one material.
- the material used is titanium or some other inert material suitable for use in a wide variety of medical applications.
- the active mechanism in each embodiment a pump or motor, is completely sealed off from the drug to be delivered. Further, there are no small passages for the drug to travel through, and the amount of dead space is minimized. Finally, the active mechanism is able to empty and refill the reservoir, eliminating the need for medical personnel to do so. This minimizes the possibility of overfilling.
- FIG. 1 is a schematic illustration of a conventional implantable drug infusion device.
- FIG. 2 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and including a diaphragm and a hydraulic displacement mechanism.
- FIG. 3 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and including a piston and a hydraulic displacement method.
- FIG. 4 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and incorporating direct mechanical displacement by a motor and lead screw.
- FIG. 5 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and incorporating direct mechanical displacement by a worm gear.
- FIG. 6 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and incorporating a spring forced bellows urgeable from a relaxed collapsed position by a pulley mechanism.
- prior implantable drug infusion devices generally comprise an infusion assembly 10 including an internal drug reservoir 12 and a pump 14 .
- a drug that is to be delivered to a specific desired location within a patient's body is supplied manually via a hypodermic needle 16 inserted into the reservoir 12 .
- Access to the reservoir 12 is achieved through an access port 18 by inserting the needle 16 through the septum 20 which otherwise acts to prevent fluids or other substances from gaining entry to or leaving the reservoir 12 .
- the pump 14 pulls the drug to be infused to the patient from reservoir 12 via exitway 22 . After passing through pump 14 , the drug is delivered via outlet line 24 to the desired location within the patient's body.
- the first configuration of what for convenience is termed herein as the “hydraulic” embodiment of the present invention includes three separate reservoirs: a drug reservoir 30 , an intermediate reservoir 32 , and a lower reservoir 34 .
- the drug to be infused to a desired location within a patient's body is introduced into reservoir 30 via needle 36 inserted through septum 38 disposed within access port 40 .
- intermediate chamber 32 initially contains a working fluid such as sterile water, sterile saline, silicone oil, or a lubricant.
- a membrane or diaphragm 48 separates drug reservoir 30 from intermediate reservoir 32 .
- the pump 42 draws working fluid from intermediate chamber 32 and delivers the withdrawn fluid into lower chamber 34 .
- the volume of fluid in intermediate chamber 32 decreases, the size of chamber 32 will decrease too, and drug fluid will be drawn into reservoir 30 from the supply needle 36 .
- the change in volumes of reservoirs 30 and 32 is possible in view of the use of the bellows-like sidewall 44 .
- the amount of working fluid transferred from intermediate chamber 32 to lower chamber 34 varies according to the desired amount of drug to be drawn into drug reservoir 30 .
- the delivery of drug to the patient is also controlled.
- the pump 42 is programmable, allowing the physician or other clinician to set the rate and/or pattern of the transfer of the working fluid, and hence the rate and/or pattern for the infusion of drug fluid.
- FIG. 3 A second configuration of the “hydraulic” embodiment of the present invention is shown in FIG. 3.
- the structure of this second configuration generally resembles that of the first configuration.
- Drug is introduced into reservoir 50 via a needle 52 inserted through septum 54 disposed within access port 56 .
- a pump 58 acts to transfer a working fluid between intermediate chamber 60 and a lower chamber 62 .
- the drug is infused to the patient's body through exitway 64 by the action of pump 58 , the transfer of the working fluid, and the displacement of the reservoir 50 , much like the infusion takes place within the first configuration.
- the second hydraulic configuration includes, instead of a membrane, a sliding piston 66 adapted with a seal 68 to separate intermediate chamber 60 from drug reservoir 50 .
- the seal 68 helps to ensure that no fluid or drug is transferred between chambers 50 and 60 .
- the second preferred embodiment of the present invention generally is directed to an assembly that uses mechanical, screw-type displacement of a drug reservoir to deliver pharmaceutical agents or other fluids to a specific desired locations within a patient's body. Again, there are two general configurations of this preferred embodiment.
- a motor 70 is operatively coupled to a lead screw 72 , so that as the motor 70 rotates the screw 72 , a nut 74 is displaced along the longitudinal axis of the screw 72 .
- the nut 74 is operatively coupled to both lead screw 72 and the base of drug reservoir 76 , so that displacement of the nut 74 in either direction along the axis of screw 72 results in a corresponding displacement of the base of the drug reservoir 76 .
- sidewall 78 and inner wall 80 comprise a donut-shaped bellows-like assembly that permits the volume change to occur.
- the introduction and expulsion of the drug to and from the drug reservoir 76 is accomplished much like in the first preferred embodiment of the present invention, i.e., by displacement of the drug reservoir itself. Again, access to the reservoir 76 may be had by way of a needle 82 inserted through a septum 84 disposed within access port 86 , and the drug exits the reservoir 76 via exitway 88 .
- FIG. 5 The second configuration of the second preferred embodiment is shown in FIG. 5.
- a motor 90 drives a worm gear 92 that meshes with a toothed bar or rack 94 .
- the rack 94 is fixedly attached or otherwise operatively coupled on one end to the bottom of the drug reservoir 96 .
- the drug reservoir 96 is shown as having flexible, i.e., collapsible sides 98 , rather than bellows-like sides as in the other Figures.
- the exact shape of the sides is not necessarily critical; of primary importance is that the sides allow the reservoir 96 to be displaced, so that drug introduced by needle 100 through septum 102 disposed in port 104 may be delivered via exitway 106 to a specific desired location in the patient's body.
- the drug infusion assembly comprises a reservoir 108 including a base 110 and bellows 112 .
- the bellows 112 preferably is annealed in a bellows-like shape so that in its natural state the wall is collapsed, i.e., in a condition corresponding to the state of lowest volume of the reservoir 108 .
- a motor 114 is operatively coupled to a pulley or flywheel 116 .
- a wire, rope, cord, chain or similar such connecting means 118 is coupled on one end to the base 110 , and on its other end to the flywheel 116 .
- the flywheel 116 turns and wraps the connecting means 118 about the flywheel 116 , so that the base 110 is displaced, increasing the volume of the reservoir 108 .
- drug or other fluids to be infused to the patient may be introduced into the reservoir 108 from the needle 120 extending through septum 122 disposed in port 124 in the manner described above.
- the annealing of the bellows 112 ensures that the reservoir acts like a spring; that is, in tending toward a natural state, the reservoir places in tension the connecting means 118 .
- the direction of the motor 114 is reversed, so that the reservoir is displaced back toward its natural state. As the volume of the reservoir decreases, the drug is forced to exit through opening 126 .
- the motor 114 like the motors and pumps of the other embodiments, may be programmed so that delivery of the drug takes place at a desired rate or pattern.
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
The present disclosure describes a system wherein a drug or other fluid to be delivered to a specific desired location within the body is stored in a reservoir that is directly displaced by a force to infuse the drug from the device into the patient. Several specific methods are used to displace the reservoir, including, generally, hydraulic displacement, mechanical screw-type displacement, and spring force displacement of the fluid reservoir.
Description
- The present invention relates generally to a method and apparatus for the delivery of fluids to a desired location within the body; and more particularly, relates to an implantable drug infusion device for delivery of pharmaceutical agents or other fluids directly from a reservoir within the device to a specific desired location within a patient's body.
- Implantable drug infusion devices usually are implanted for several years, during which time there is no opportunity to service or repair these devices. Accordingly, both the implanted device and the drug to be infused must remain operative and be stable for a long period.
- The current trend is toward extending significantly the intended life of implanted drug infusion devices. Further, new drugs having different physical and chemical properties are continually being developed, the use of which may not be sufficiently compatible or properly interactive with current devices.
- Conventional implantable fluid delivery systems for drug infusion typically include a reservoir to store the fluid, and a separate pump or other flow control device to deliver the fluid. This type of implantable drug infusion system is shown generally in FIG. 1. Reservoirs in conventional implanted drug infusion devices undergo little motion, so that the materials which form the reservoir can be selected primarily for compatibility with the drug that is to be delivered. Pumps, on the other hand, typically have many moving parts. The materials from which the pumps are made thus must be selected for specific mechanical properties, such as flexibility, durability, and strength. The materials used may not exhibit all desirable mechanical properties, or may not be compatible with some drugs to be infused. An example is a silicone tube in a peristaltic pump. Silicone is very flexible and durable, but is permeable to many fluids and is not as strong as other elastomers.
- With respect to another incongruity of design objectives, because implantable infusion devices preferably are small in size, the devices typically have only limited internal space, so that any materials used in the manufacture of the device must be of the type that can be used to manufacture very small parts. One example of such a material is silicon formed by micromachining. Silicon, however, is difficult to join to other materials.
- Along the same lines, although it is desirable to have implantable fluid delivery systems that are small in size, the reduced size of certain conventional devices can be problematic in some applications. For example, pumps or valves with very small passages are not able to effectively deliver certain fluids. Some drugs, such as insulin, often are damaged by shear forces when flowing through such small passages.
- Finally, another design incongruity arises with conventional drug infusion devices in which the drug is routed from the reservoir to the pump, and then to the device outlet where it is delivered to a desired location within the body. A certain amount of the drug thus is contained in the pump and fluid passages. This fluid, held in what commonly is referred to as the “dead space,” must be displaced whenever the drug in the reservoir is changed. Delivery systems with relatively more dead space require more unused, unwanted drug to be infused before the drug can be changed.
- The fluid delivery assembly and method of the present invention overcomes the above-noted and other shortcomings of prior drug infusion systems. In accordance with the present invention, a drug or other fluid to be delivered to a specific desired location within the body is stored in a reservoir that is directly displaced by a force to infuse the drug from the device into the patient. Several methods can be used to displace the reservoir, which are described in more detail below. For simplicity the present invention is described herein in terms of three presently preferred embodiments which include, generally, hydraulic displacement, mechanical screw-type displacement, and spring force displacement of the fluid reservoir. However, one of ordinary skill in the art having the benefit of this disclosure will recognize that the invention is not limited strictly to the embodiments described herein. The Figures and other description contained herein is merely illustrative of the present invention. Actual implementation of the present invention in an implantable drug infusion device will undoubtedly vary depending upon the particular circumstances involved with its intended use, particularly with respect to the exact shape, size, specifications, etc. of the device. In any event each embodiment herein described incorporates the teachings of the present invention, and achieves the advantages of (a) eliminating contact and interaction between the drug and, other materials, including those comprising the pump; (b) eliminating small drug passages, for example, through the pump; and (c) of allowing controlled filling and emptying of the drug reservoir.
- The first preferred method of displacing the reservoir, given as an example, is hydraulic. See FIGS. 2 and 3. In this configuration, three separate reservoir compartments are used along with a separate pump. The pump does not contact the drug, but recirculates a working fluid inside the device. The working fluid can be selected to be non-corrosive, or even to enhance the operation of the pump. Again, the choice of working fluid depends upon the circumstances involved in a particular application. However, examples of working fluids include sterile water, sterile saline, silicone oil, or a lubricant.
- In operation, the pump withdraws the working fluid from the bottom reservoir and pumps it into an intermediate reservoir under the drug reservoir. The drug and intermediate reservoirs are separated by, for example, a diaphragm (See FIG. 2) or a piston (See FIG. 3). Of particular importance is that the drug and intermediate reservoirs be sealed, so that no fluid may pass from one into the other.
- As the intermediate reservoir fills, and the drug reservoir is displaced, the drug is forced out of the device. The pump is programmable to any pattern or rate utilized in an implantable device. The drug infusion will follow the rate or pattern programmed. Examples of program rates and patterns include those commonly used with the SynchroMed™ Programmable Pump, available commercially from Medtronic, Inc., Minneapolis, Minn.
- A means of maintaining constant pressure in the device, such as a volatile fluid, is required under the internal drug reservoir. To refill the drug reservoir, a syringe is introduced into the reservoir via a hypodermic needle. The drug exit path is closed and the pump is then reversed to draw the drug from the syringe into the reservoir. This method also eliminates the possibility of forcing the drug into the reservoir with the syringe and damaging the device or over-infusing the drug.
- In the second preferred embodiment, the internal drug reservoir is directly displaced mechanically, either by a motor and lead screw (See FIG. 4) or a motor and worm gear (See FIG. 5).
- In the first configuration of the second preferred embodiment, the motor rotates and displaces a nut on the lead screw. The nut is attached directly to the reservoir base and directly displaces it as it moves. This system is less susceptible to changes in pressure inside the device during operation. However, a volatile fluid still may be used to ensure that a relatively constant internal pressure is maintained. Again, the motor may be programmed to any pattern or rate, such as those used in commercially available implantable devices like the SynchroMed™, and the motor is reversed to refill the drug reservoir. This first configuration is most suited for a donut-type bellows to ensure that no contaminant reaches the interior of the drug reservoir.
- In the second configuration of the second preferred embodiment of the present invention, a motor rotates a worm gear that displaces a rack coupled to the bottom portion of the drug reservoir. A flexible side bellows allows the drug reservoir base to be displaced upwards as the worm gear turns, forcing drug from the reservoir to the desired delivery site. Again, the motor may be programmed so that drug is delivered at a desired rate or pattern, and may be reversed to facilitate the refilling of the drug reservoir. The side bellows are hermetically sealed to keep the drug free of possible contamination from unwanted sources, and to protect any adverse impact which might result from their contacting the drugs.
- The third embodiment of the present invention utilizes the spring force of the reservoir bellows to displace the drug reservoir. The bellows is annealed, so that in its relaxed, natural state it is completely collapsed. In this configuration (See FIG. 6), the bellows is expanded by a device such as a motor which turns a flywheel or pulley to wind one end of a cable about the pulley or flywheel, the other end of the cable being connected to the bottom of the drug reservoir. Once the reservoir is filled, the pulley/cable is relaxed to allow the bellows to return to its natural, collapsed state. Again, the motor may be programmed to any pattern or rate to ensure that the displaced drug is delivered according to the desired schedule, and the motor may be programmed to allow for controlled refilling.
- As stated above, and although the present invention described herein in terms of three separate embodiments, there are certain advantages which all three embodiments share over prior devices. For example, again, in each embodiment the drug contacts only one material. Preferably, the material used is titanium or some other inert material suitable for use in a wide variety of medical applications. Moreover, the active mechanism in each embodiment, a pump or motor, is completely sealed off from the drug to be delivered. Further, there are no small passages for the drug to travel through, and the amount of dead space is minimized. Finally, the active mechanism is able to empty and refill the reservoir, eliminating the need for medical personnel to do so. This minimizes the possibility of overfilling.
- FIG. 1 is a schematic illustration of a conventional implantable drug infusion device.
- FIG. 2 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and including a diaphragm and a hydraulic displacement mechanism.
- FIG. 3 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and including a piston and a hydraulic displacement method.
- FIG. 4 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and incorporating direct mechanical displacement by a motor and lead screw.
- FIG. 5 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and incorporating direct mechanical displacement by a worm gear.
- FIG. 6 is a schematic illustration of an embodiment of an implantable drug infusion device according to the present invention and incorporating a spring forced bellows urgeable from a relaxed collapsed position by a pulley mechanism.
- As shown in FIG. 1, prior implantable drug infusion devices generally comprise an
infusion assembly 10 including aninternal drug reservoir 12 and apump 14. A drug that is to be delivered to a specific desired location within a patient's body is supplied manually via ahypodermic needle 16 inserted into thereservoir 12. Access to thereservoir 12 is achieved through anaccess port 18 by inserting theneedle 16 through theseptum 20 which otherwise acts to prevent fluids or other substances from gaining entry to or leaving thereservoir 12. Thepump 14 pulls the drug to be infused to the patient fromreservoir 12 viaexitway 22. After passing throughpump 14, the drug is delivered viaoutlet line 24 to the desired location within the patient's body. - The use of prior implantable drug infusion devices such as the one shown generally in FIG. 1 has significant drawbacks. However, as noted above, the present invention overcomes these shortcomings. In particular, it should be noted that the drug in
pump 10 contacts multiple different materials, that thepump 14 is in contact with the drug, that the drug must traverse any small passageway inpump 14, and that the rate of introduction of drug intoreservoir 12 is controlled solely by the clinician filling the device and is not metered bypump 10. - As shown in FIG. 2, the first configuration of what for convenience is termed herein as the “hydraulic” embodiment of the present invention includes three separate reservoirs: a
drug reservoir 30, anintermediate reservoir 32, and alower reservoir 34. The drug to be infused to a desired location within a patient's body is introduced intoreservoir 30 vianeedle 36 inserted throughseptum 38 disposed withinaccess port 40. - In accordance with the present invention,
intermediate chamber 32 initially contains a working fluid such as sterile water, sterile saline, silicone oil, or a lubricant. A membrane ordiaphragm 48 separatesdrug reservoir 30 fromintermediate reservoir 32. Once thedelivery needle 36 is inserted in place so that its tip is withinreservoir 30, thepump 42 draws working fluid fromintermediate chamber 32 and delivers the withdrawn fluid intolower chamber 34. As the volume of fluid inintermediate chamber 32 decreases, the size ofchamber 32 will decrease too, and drug fluid will be drawn intoreservoir 30 from thesupply needle 36. The change in volumes ofreservoirs sidewall 44. The amount of working fluid transferred fromintermediate chamber 32 tolower chamber 34 varies according to the desired amount of drug to be drawn intodrug reservoir 30. - Once
drug reservoir 30 holds a desired amount of drug fluid, and theneedle 36 has been withdrawn, delivery of the drug to a specific desired location within a patient's body viaoutlet line 46 is accomplished by reversingpump 42. That is, pump 42 draws working fluid fromlower chamber 34 and injects it intointermediate chamber 32. When this occurs, the volume ofintermediate chamber 32 increases, andmembrane 48 is displaced, so that the size ofdrug reservoir 30 decreases and drug is forced out throughexitway 46. - Thus, by controlling the operation of
pump 42, the delivery of drug to the patient is also controlled. Preferably, thepump 42 is programmable, allowing the physician or other clinician to set the rate and/or pattern of the transfer of the working fluid, and hence the rate and/or pattern for the infusion of drug fluid. - A second configuration of the “hydraulic” embodiment of the present invention is shown in FIG. 3. The structure of this second configuration generally resembles that of the first configuration. Drug is introduced into
reservoir 50 via aneedle 52 inserted throughseptum 54 disposed withinaccess port 56. Apump 58 acts to transfer a working fluid betweenintermediate chamber 60 and alower chamber 62. The drug is infused to the patient's body throughexitway 64 by the action ofpump 58, the transfer of the working fluid, and the displacement of thereservoir 50, much like the infusion takes place within the first configuration. However, the second hydraulic configuration includes, instead of a membrane, a slidingpiston 66 adapted with aseal 68 to separateintermediate chamber 60 fromdrug reservoir 50. Theseal 68 helps to ensure that no fluid or drug is transferred betweenchambers - The second preferred embodiment of the present invention generally is directed to an assembly that uses mechanical, screw-type displacement of a drug reservoir to deliver pharmaceutical agents or other fluids to a specific desired locations within a patient's body. Again, there are two general configurations of this preferred embodiment.
- In the first configuration, shown in FIG. 4, a
motor 70 is operatively coupled to alead screw 72, so that as themotor 70 rotates thescrew 72, anut 74 is displaced along the longitudinal axis of thescrew 72. Thenut 74 is operatively coupled to bothlead screw 72 and the base ofdrug reservoir 76, so that displacement of thenut 74 in either direction along the axis ofscrew 72 results in a corresponding displacement of the base of thedrug reservoir 76. - As the base of the
drug reservoir 76 moves, the volume of thedrug chamber 76 changes. Preferably,sidewall 78 andinner wall 80 comprise a donut-shaped bellows-like assembly that permits the volume change to occur. - The introduction and expulsion of the drug to and from the
drug reservoir 76 is accomplished much like in the first preferred embodiment of the present invention, i.e., by displacement of the drug reservoir itself. Again, access to thereservoir 76 may be had by way of aneedle 82 inserted through aseptum 84 disposed withinaccess port 86, and the drug exits thereservoir 76 viaexitway 88. - The second configuration of the second preferred embodiment is shown in FIG. 5. A
motor 90 drives aworm gear 92 that meshes with a toothed bar orrack 94. Therack 94 is fixedly attached or otherwise operatively coupled on one end to the bottom of thedrug reservoir 96. Thedrug reservoir 96 is shown as having flexible, i.e.,collapsible sides 98, rather than bellows-like sides as in the other Figures. The exact shape of the sides is not necessarily critical; of primary importance is that the sides allow thereservoir 96 to be displaced, so that drug introduced byneedle 100 throughseptum 102 disposed inport 104 may be delivered viaexitway 106 to a specific desired location in the patient's body. - The third preferred embodiment of the present invention is shown in FIG. 6. The drug infusion assembly comprises a
reservoir 108 including abase 110 and bellows 112. Thebellows 112 preferably is annealed in a bellows-like shape so that in its natural state the wall is collapsed, i.e., in a condition corresponding to the state of lowest volume of thereservoir 108. Amotor 114 is operatively coupled to a pulley orflywheel 116. A wire, rope, cord, chain or similar such connectingmeans 118 is coupled on one end to thebase 110, and on its other end to theflywheel 116. As themotor 114 turns in one direction, theflywheel 116 turns and wraps the connecting means 118 about theflywheel 116, so that thebase 110 is displaced, increasing the volume of thereservoir 108. As the volume of thereservoir 108 is increased, drug or other fluids to be infused to the patient may be introduced into thereservoir 108 from theneedle 120 extending throughseptum 122 disposed inport 124 in the manner described above. The annealing of thebellows 112 ensures that the reservoir acts like a spring; that is, in tending toward a natural state, the reservoir places in tension the connectingmeans 118. - To deliver drug to the patient, then, the direction of the
motor 114 is reversed, so that the reservoir is displaced back toward its natural state. As the volume of the reservoir decreases, the drug is forced to exit throughopening 126. Themotor 114, like the motors and pumps of the other embodiments, may be programmed so that delivery of the drug takes place at a desired rate or pattern. - Although the preferred embodiment of this invention has been described hereinabove in some detail, it should be appreciated that a variety of embodiments will be readily available to persons utilizing the invention for a specific end use. The description of the apparatus and method of this invention is not intended to be limiting on this invention, but is merely illustrative of the preferred embodiment of this invention. Other apparatus and methods which incorporate modifications or changes to that which has been described herein are equally included within this application. Additional objects, features and advantages of the present invention will become apparent by referring to the above description of the invention in connection with the accompanying drawings.
Claims (22)
1. A drug infusion device, comprising:
a fluid reservoir; and
fluid reservoir displacement means for directly forcing drug fluid within said fluid reservoir from said device.
2. The apparatus of , wherein said fluid reservoir displacement means comprises hydraulic displacement means.
claim 1
3. The apparatus of , wherein said hydraulic displacement means comprises a pump which circulates a working fluid between a first reservoir and an expandable second reservoir disposed proximate said fluid reservoir, so that as said second reservoir expands, said fluid reservoir is displaced.
claim 2
4. The apparatus of , wherein said hydraulic displacement means comprises a piston assembly which acts to directly displace said fluid reservoir.
claim 2
5. The apparatus of , wherein said fluid reservoir displacement means comprises mechanical screw-type displacement means.
claim 1
6. The apparatus of , wherein said mechanical screw-type displacement means comprises a motor operatively coupled to a lead screw, so that as the motor turns the lead screw about a central axis, a nut coupled to said fluid reservoir and disposed on said lead screw is displaced along said central axis, displacing said fluid reservoir.
claim 5
7. The apparatus of , wherein said mechanical screw-type displacement means comprises a motor that rotates a worm gear to displace a rack coupled to the fluid reservoir, displacing said fluid reservoir.
claim 5
8. The apparatus of , wherein said fluid reservoir displacement means comprises spring force displacement means.
claim 1
9. The apparatus of , wherein the spring force displacement means comprises a bellows-like expandable chamber annealed so that the chamber in its natural state assumes a collapsed position, and in an expanded state the chamber tends toward its natural collapsed position under its own action.
claim 8
10. The apparatus of , wherein said spring force displacement means further comprises a motor assembly, including a motor operatively coupled to a flywheel about which a first end of a cable having first and second ends is wrapped, said second end of said cable being attached to said bellows-like expandable chamber and wherein said motor assembly adjusts the position of the bellows-like expandable chamber as it relaxes from a first expanded state to a second more collapsed state to control the displacement of the fluid reservoir.
claim 9
11. A drug infusion device, comprising:
a fluid reservoir; and
fluid reservoir displacement means for directly drawing drug fluid into said fluid reservoir.
12. The apparatus of , wherein said fluid reservoir displacement means comprises hydraulic displacement means.
claim 11
13. The apparatus of , wherein said hydraulic displacement means comprises a pump which circulates a working fluid between a first reservoir and a contractible second reservoir disposed proximate said fluid reservoir, so that as said second reservoir contracts, said fluid reservoir is displaced.
claim 12
14. The apparatus of , wherein said hydraulic displacement means comprises a piston assembly which acts to directly displace said fluid reservoir.
claim 12
15. The apparatus of , wherein said fluid reservoir displacement means comprises mechanical screw-type displacement means.
claim 11
16. The apparatus of , wherein said mechanical screw-type displacement means comprises a motor operatively coupled to a lead screw, so that as the motor turns the lead screw about a central axis, a nut coupled to said fluid reservoir and disposed on said lead screw is displaced along said central axis, displacing said fluid reservoir.
claim 15
17. The apparatus of , wherein said mechanical screw-type displacement means comprises a motor that rotates a worm gear to displace a rack coupled to the fluid reservoir, displacing said fluid reservoir.
claim 15
18. The apparatus of , wherein said fluid reservoir displacement means comprises spring force displacement means.
claim 11
19. The apparatus of , wherein, the spring force displacement means comprises a bellows-like expandable chamber annealed so that the chamber in its natural state assumes a collapsed position, and in an expanded state the chamber tends toward its natural collapsed position under its own action.
claim 18
20. The apparatus of , wherein said spring force displacement means further comprises a motor assembly, including a motor operatively coupled to a flywheel about which a first end of a cable having first and second ends is wrapped, said second end of said cable being attached to said bellows-like expandable chamber; and wherein said motor assembly adjusts the position of the bellows-like expandable chamber from a first contracted state to a second more expanded state to displace the fluid reservoir.
claim 19
21. A method of infusing a drug to a specific desired location within a patient's body, comprising:
placing a measure of the drug within a fluid reservoir and forcing at least a portion of the drug from the fluid reservoir and through an established fluid passageway extending between the fluid reservoir and the specific desired location within the patient's body by directly displacing said fluid reservoir.
22. A method of filling a drug reservoir in an implantable drug infusion device, comprising:
providing a supply of fluid; and
directly displacing said fluid reservoir to draw at least a portion of the provided supply of fluid into said fluid reservoir.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/416,151 US6394981B2 (en) | 1996-04-30 | 1999-10-11 | Method and apparatus for drug infusion |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/641,362 US5976109A (en) | 1996-04-30 | 1996-04-30 | Apparatus for drug infusion implanted within a living body |
US09/416,151 US6394981B2 (en) | 1996-04-30 | 1999-10-11 | Method and apparatus for drug infusion |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/641,362 Division US5976109A (en) | 1996-04-30 | 1996-04-30 | Apparatus for drug infusion implanted within a living body |
Publications (2)
Publication Number | Publication Date |
---|---|
US20010031947A1 true US20010031947A1 (en) | 2001-10-18 |
US6394981B2 US6394981B2 (en) | 2002-05-28 |
Family
ID=24572037
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/641,362 Expired - Lifetime US5976109A (en) | 1996-04-30 | 1996-04-30 | Apparatus for drug infusion implanted within a living body |
US09/416,151 Expired - Fee Related US6394981B2 (en) | 1996-04-30 | 1999-10-11 | Method and apparatus for drug infusion |
US09/415,809 Expired - Fee Related US6190359B1 (en) | 1996-04-30 | 1999-10-11 | Method and apparatus for drug infusion |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US08/641,362 Expired - Lifetime US5976109A (en) | 1996-04-30 | 1996-04-30 | Apparatus for drug infusion implanted within a living body |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/415,809 Expired - Fee Related US6190359B1 (en) | 1996-04-30 | 1999-10-11 | Method and apparatus for drug infusion |
Country Status (1)
Country | Link |
---|---|
US (3) | US5976109A (en) |
Cited By (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1600120A1 (en) * | 2004-05-28 | 2005-11-30 | Ethicon Endo-Surgery, Inc. | Metal bellows position feedback for hydraulic control of an adjustable gastric band |
US20060084926A1 (en) * | 2004-07-15 | 2006-04-20 | P. Rowan Smith, Jr. | Compression bulb hypodermic syring |
US20060253068A1 (en) * | 2005-04-20 | 2006-11-09 | Van Bilsen Paul | Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart |
US20070167389A1 (en) * | 2003-11-25 | 2007-07-19 | Kaemmerer William F | Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
US20070261126A1 (en) * | 2005-05-06 | 2007-11-08 | Kaemmerer William F | Methods and sequences to suppress primate huntington gene expression in vivo |
US20080039415A1 (en) * | 2006-08-11 | 2008-02-14 | Gregory Robert Stewart | Retrograde transport of sirna and therapeutic uses to treat neurologic disorders |
US20080119787A1 (en) * | 2006-11-21 | 2008-05-22 | Kaemmerer William F | Microsyringe for pre-packaged delivery of pharmaceuticals |
US20080124379A1 (en) * | 2006-11-03 | 2008-05-29 | Kaemmerer William F | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
US20080171906A1 (en) * | 2007-01-16 | 2008-07-17 | Everaerts Frank J L | Tissue performance via hydrolysis and cross-linking |
US20080280843A1 (en) * | 2006-05-24 | 2008-11-13 | Van Bilsen Paul | Methods and kits for linking polymorphic sequences to expanded repeat mutations |
US20090060987A1 (en) * | 2002-11-26 | 2009-03-05 | Kaemmerer William F | Devices, systems and methods for improving memory and/or cognitive function through brain delivery of sirna |
US7605249B2 (en) | 2002-11-26 | 2009-10-20 | Medtronic, Inc. | Treatment of neurodegenerative disease through intracranial delivery of siRNA |
US20100008981A1 (en) * | 2005-05-06 | 2010-01-14 | Medtronic, Inc. | Methods and sequences to suppress primate huntington gene expression |
US7819842B2 (en) | 2006-11-21 | 2010-10-26 | Medtronic, Inc. | Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites |
US7829694B2 (en) | 2002-11-26 | 2010-11-09 | Medtronic, Inc. | Treatment of neurodegenerative disease through intracranial delivery of siRNA |
US20100312164A1 (en) * | 2008-01-28 | 2010-12-09 | Peter Forsell | Implantable drainage device |
KR101030391B1 (en) | 2009-05-22 | 2011-04-20 | 국립암센터 | Drug reservoir for intrathecal drug infusion device |
US20110213328A1 (en) * | 2004-03-18 | 2011-09-01 | Medtronic, Inc. | Methods and Systems for Treatment of Neurological Diseases of the Central Nervous System |
US8324367B2 (en) | 2006-11-03 | 2012-12-04 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
US8957198B2 (en) | 2003-02-03 | 2015-02-17 | Medtronic, Inc. | Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna |
US9133517B2 (en) | 2005-06-28 | 2015-09-15 | Medtronics, Inc. | Methods and sequences to preferentially suppress expression of mutated huntingtin |
US9273356B2 (en) | 2006-05-24 | 2016-03-01 | Medtronic, Inc. | Methods and kits for linking polymorphic sequences to expanded repeat mutations |
WO2019038751A1 (en) * | 2017-08-22 | 2019-02-28 | Steadymed, Ltd | Selectively mechanically activatable prefilled infusion-pump devices |
CN110141720A (en) * | 2019-06-21 | 2019-08-20 | 青岛大学附属医院 | A kind of operating room transfusion bags heat-insulating pressurizing device |
US10687676B2 (en) * | 2017-06-09 | 2020-06-23 | Hamilton Sundstrand Corporation | Microgravity urine collection and storage |
EP4056210A1 (en) * | 2021-03-12 | 2022-09-14 | Insulet Corporation | Pumping mechanism with wire-pulled plunger |
Families Citing this family (179)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5976109A (en) | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body |
US6485462B1 (en) | 1997-08-27 | 2002-11-26 | Science Incorporated | Fluid delivery device with heat activated energy source |
US6635049B1 (en) * | 1999-04-30 | 2003-10-21 | Medtronic, Inc. | Drug bolus delivery system |
US6283949B1 (en) | 1999-12-27 | 2001-09-04 | Advanced Cardiovascular Systems, Inc. | Refillable implantable drug delivery pump |
US6764472B1 (en) | 2000-01-11 | 2004-07-20 | Bard Access Systems, Inc. | Implantable refillable infusion device |
US6629954B1 (en) | 2000-01-31 | 2003-10-07 | Medtronic, Inc. | Drug delivery pump with isolated hydraulic metering |
US6669669B2 (en) * | 2001-10-12 | 2003-12-30 | Insulet Corporation | Laminated patient infusion device |
CN1471413A (en) | 2000-09-08 | 2004-01-28 | Devices, systems and methods for patient infusion | |
US20040034321A1 (en) * | 2000-10-05 | 2004-02-19 | Seacoast Technologies, Inc. | Conformal pad for neurosurgery and method thereof |
WO2002028331A1 (en) | 2000-10-05 | 2002-04-11 | Seacoast Technologies, Inc. | Expandable device for thermal therapy including spiral element |
US6540655B1 (en) | 2000-11-10 | 2003-04-01 | Scimed Life Systems, Inc. | Miniature x-ray unit |
US6554757B1 (en) | 2000-11-10 | 2003-04-29 | Scimed Life Systems, Inc. | Multi-source x-ray catheter |
US6546080B1 (en) * | 2000-11-10 | 2003-04-08 | Scimed Life Systems, Inc. | Heat sink for miniature x-ray unit |
US6540720B1 (en) | 2000-11-10 | 2003-04-01 | Scimed Life Systems, Inc. | Miniature x-ray unit |
US6551278B1 (en) * | 2000-11-10 | 2003-04-22 | Scimed Life Systems, Inc. | Miniature x-ray catheter with retractable needles or suction means for positioning at a desired site |
CA2431420C (en) | 2000-12-21 | 2011-10-11 | Insulet Corporation | Medical apparatus remote control and method |
WO2002068015A2 (en) | 2001-02-22 | 2002-09-06 | Insulet Corporation | Modular infusion device and method |
US6726678B1 (en) * | 2001-02-22 | 2004-04-27 | Isurgical, Llc | Implantable reservoir and system for delivery of a therapeutic agent |
US6663615B1 (en) | 2001-09-04 | 2003-12-16 | The Ohio State University | Dual stage microvalve and method of use |
US20040073175A1 (en) * | 2002-01-07 | 2004-04-15 | Jacobson James D. | Infusion system |
US6692457B2 (en) * | 2002-03-01 | 2004-02-17 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US6830558B2 (en) | 2002-03-01 | 2004-12-14 | Insulet Corporation | Flow condition sensor assembly for patient infusion device |
US20030176797A1 (en) * | 2002-03-12 | 2003-09-18 | Fernando Anzellini | Thrombust; implantable delivery system sensible to self diagnosis of acute myocardial infarction for thrombolysis in the first minutes of chest pain |
US6656158B2 (en) * | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
US20040153032A1 (en) * | 2002-04-23 | 2004-08-05 | Garribotto John T. | Dispenser for patient infusion device |
US6656159B2 (en) * | 2002-04-23 | 2003-12-02 | Insulet Corporation | Dispenser for patient infusion device |
US20050238507A1 (en) * | 2002-04-23 | 2005-10-27 | Insulet Corporation | Fluid delivery device |
US7018360B2 (en) * | 2002-07-16 | 2006-03-28 | Insulet Corporation | Flow restriction system and method for patient infusion device |
US7527608B2 (en) * | 2002-08-12 | 2009-05-05 | Lma North America, Inc. | Medication infusion and aspiration system and method |
US7128727B2 (en) * | 2002-09-30 | 2006-10-31 | Flaherty J Christopher | Components and methods for patient infusion device |
US7144384B2 (en) * | 2002-09-30 | 2006-12-05 | Insulet Corporation | Dispenser components and methods for patient infusion device |
US20040116866A1 (en) * | 2002-12-17 | 2004-06-17 | William Gorman | Skin attachment apparatus and method for patient infusion device |
CA2508124A1 (en) * | 2002-12-19 | 2004-07-08 | Alza Corporation | Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
US7731947B2 (en) | 2003-11-17 | 2010-06-08 | Intarcia Therapeutics, Inc. | Composition and dosage form comprising an interferon particle formulation and suspending vehicle |
US7559926B1 (en) | 2003-01-13 | 2009-07-14 | Advanced Neuromodulation Systems, Inc. | Actuation system and method for an implantable infusion pump |
CN1767815A (en) * | 2003-03-31 | 2006-05-03 | 阿尔萨公司 | Non-aqueous single phase vehicles and formulations utilizing such vehicles |
CA2520610A1 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Osmotic pump with means for dissipating internal pressure |
CA2520766A1 (en) * | 2003-03-31 | 2004-10-21 | Alza Corporation | Osmotic delivery system and method for decreasing start-up times for osmotic delivery systems |
US20050182366A1 (en) * | 2003-04-18 | 2005-08-18 | Insulet Corporation | Method For Visual Output Verification |
AU2012201924B2 (en) * | 2003-04-23 | 2015-06-18 | Mannkind Corporation | Hydraulically actuated pump for long duration medicament administration |
AU2015207890B2 (en) * | 2003-04-23 | 2017-02-16 | Mannkind Corporation | Hydraulically actuated pump for long duration medicament administration |
CA2820537C (en) * | 2003-04-23 | 2015-10-20 | Valeritas, Inc. | Hydraulically actuated pump for fluid administration |
US20040220551A1 (en) * | 2003-04-30 | 2004-11-04 | Flaherty J. Christopher | Low profile components for patient infusion device |
CA2525647A1 (en) | 2003-05-16 | 2005-02-24 | Intermune, Inc. | Synthetic chemokine receptor ligands and methods of use thereof |
US20040243207A1 (en) * | 2003-05-30 | 2004-12-02 | Olson Donald R. | Medical implant systems |
WO2005002642A2 (en) * | 2003-06-25 | 2005-01-13 | Medical Research Products-A, Inc. | Medication infusion device using negatively biased ambient pressure medication chamber |
WO2005007223A2 (en) * | 2003-07-16 | 2005-01-27 | Sasha John | Programmable medical drug delivery systems and methods for delivery of multiple fluids and concentrations |
US7169128B2 (en) * | 2003-08-04 | 2007-01-30 | Bioquiddity, Inc. | Multichannel fluid delivery device |
US7220244B2 (en) * | 2003-08-04 | 2007-05-22 | Bioquiddity, Inc. | Infusion apparatus with constant force spring energy source |
US20050033232A1 (en) * | 2003-08-05 | 2005-02-10 | Kriesel Marshall S. | Infusion apparatus with modulated flow control |
US20050065760A1 (en) * | 2003-09-23 | 2005-03-24 | Robert Murtfeldt | Method for advising patients concerning doses of insulin |
US20050070847A1 (en) * | 2003-09-29 | 2005-03-31 | Van Erp Wilhelmus Petrus Martinus Maria | Rapid-exchange balloon catheter with hypotube shaft |
KR20060097008A (en) | 2003-09-30 | 2006-09-13 | 알자 코포레이션 | Osmotically driven active agent delivery device providing an ascending release profile |
WO2005040758A2 (en) * | 2003-10-24 | 2005-05-06 | Intermune, Inc. | Use of pirfenidone in therapeutic regimens |
NZ550020A (en) * | 2004-02-26 | 2011-02-25 | Linguaflex Llc | A tissue retractor for treatment of a breathing disorder comprising a shaft, a retractor, and an anchor |
US8074655B2 (en) * | 2004-02-26 | 2011-12-13 | Linguaflex, Inc. | Methods and devices for treating sleep apnea and snoring |
US10524954B2 (en) * | 2004-02-26 | 2020-01-07 | Linguaflex, Inc. | Methods and devices for treating sleep apnea and snoring |
DE102004016443B3 (en) * | 2004-04-03 | 2005-08-18 | Codman Neuro Sciences Sàrl | Valve for infusion pumps comprises a valve body formed by a cylindrical tappet which slides in a cylindrical receiver, and an inflow opening into the receiver in a region of the tappet base |
US20050266087A1 (en) * | 2004-05-25 | 2005-12-01 | Gunjan Junnarkar | Formulations having increased stability during transition from hydrophobic vehicle to hydrophilic medium |
US20050277884A1 (en) * | 2004-05-26 | 2005-12-15 | Kriesel Marshall S | Fluid delivery apparatus with bellows reservoir |
US7220245B2 (en) * | 2004-05-26 | 2007-05-22 | Kriesel Marshall S | Infusion apparatus |
US7470253B2 (en) * | 2004-05-26 | 2008-12-30 | Bioquiddity, Inc. | Fluid delivery apparatus with adjustable flow rate control |
US20070156090A1 (en) * | 2004-05-26 | 2007-07-05 | Kriesel Marshall S | Fluid delivery apparatus |
US20050277883A1 (en) * | 2004-05-26 | 2005-12-15 | Kriesel Marshall S | Fluid delivery device |
DE102004026805A1 (en) * | 2004-06-02 | 2006-01-05 | Disetronic Licensing Ag | Container for storing a product to be injected and injection device |
US9089636B2 (en) | 2004-07-02 | 2015-07-28 | Valeritas, Inc. | Methods and devices for delivering GLP-1 and uses thereof |
US20060020298A1 (en) * | 2004-07-20 | 2006-01-26 | Camilleri Michael L | Systems and methods for curbing appetite |
WO2006083761A2 (en) | 2005-02-03 | 2006-08-10 | Alza Corporation | Solvent/polymer solutions as suspension vehicles |
US11246913B2 (en) | 2005-02-03 | 2022-02-15 | Intarcia Therapeutics, Inc. | Suspension formulation comprising an insulinotropic peptide |
US20060178633A1 (en) * | 2005-02-03 | 2006-08-10 | Insulet Corporation | Chassis for fluid delivery device |
US8029468B2 (en) * | 2005-02-15 | 2011-10-04 | Bioquiddity, Inc. | Fluid delivery and mixing apparatus with flow rate control |
US20080009835A1 (en) * | 2005-02-17 | 2008-01-10 | Kriesel Marshall S | Fluid dispensing apparatus with flow rate control |
US7694938B2 (en) * | 2005-02-17 | 2010-04-13 | Bioquiddity, Inc. | Distal rate control device |
US7837653B2 (en) * | 2005-02-18 | 2010-11-23 | Bioquiddity, Inc. | Fluid delivery apparatus with vial fill |
US8840586B2 (en) * | 2006-08-23 | 2014-09-23 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7552240B2 (en) * | 2005-05-23 | 2009-06-23 | International Business Machines Corporation | Method for user space operations for direct I/O between an application instance and an I/O adapter |
US8034029B2 (en) | 2005-05-25 | 2011-10-11 | Palyon Medical (Bvi) Limited | Multi-reservoir implantable pump with patient controlled actuation |
US20070027105A1 (en) * | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
US7790671B2 (en) * | 2005-10-07 | 2010-09-07 | Codman & Shurtleff, Inc. | Implantable pump for protein delivery for obesity control by drug infusion into the brain |
US8141844B2 (en) | 2005-10-26 | 2012-03-27 | Codman NeuroSciences Sàrl | Flow rate accuracy of a fluidic delivery system |
US8240635B2 (en) * | 2005-10-26 | 2012-08-14 | Codman Neuro Sciences Sárl | Flow rate accuracy of a fluidic delivery system |
US7708730B2 (en) | 2006-01-30 | 2010-05-04 | Palyon Medical (Bvi) Limited | Template system for multi-reservoir implantable pump |
US7993304B2 (en) * | 2006-03-15 | 2011-08-09 | Bioquiddity, Inc. | Fluid dispensing apparatus |
US7828772B2 (en) * | 2006-03-15 | 2010-11-09 | Bioquiddity, Inc. | Fluid dispensing device |
ES2566058T3 (en) | 2006-03-30 | 2016-04-08 | Valeritas, Inc. | Multi-cartridge fluid supply device |
DK2020990T3 (en) | 2006-05-30 | 2010-12-13 | Intarcia Therapeutics Inc | An internal channel flow modulator for a two-part osmotic feeding system |
US8292848B2 (en) * | 2006-07-31 | 2012-10-23 | Bio Quiddity, Inc. | Fluid dispensing device with additive |
US8057435B2 (en) | 2006-07-31 | 2011-11-15 | Kriesel Joshua W | Fluid dispenser |
ES2398126T3 (en) | 2006-08-09 | 2013-03-13 | Intarcia Therapeutics, Inc | Osmotic release systems and piston units |
US7828764B2 (en) | 2006-08-23 | 2010-11-09 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7794434B2 (en) * | 2006-08-23 | 2010-09-14 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US7811262B2 (en) * | 2006-08-23 | 2010-10-12 | Medtronic Minimed, Inc. | Systems and methods allowing for reservoir filling and infusion medium delivery |
US20080097317A1 (en) * | 2006-08-25 | 2008-04-24 | Jeffery Alholm | Infusion pump |
EP2083800A4 (en) * | 2006-10-19 | 2016-10-12 | Ambu As | Device and method for patient activated bolus administration |
US20080147007A1 (en) * | 2006-12-19 | 2008-06-19 | Toby Freyman | Delivery device with pressure control |
US20080243077A1 (en) * | 2007-04-02 | 2008-10-02 | Bivin Donald B | Fluid dispenser with uniformly collapsible reservoir |
NZ580447A (en) | 2007-04-23 | 2011-06-30 | Intarcia Therapeutics Inc | Suspension formulations of insulinotropic peptides and uses thereof |
AU2008249567A1 (en) * | 2007-05-11 | 2008-11-20 | F.Hoffmann-La Roche Ag | A positive displacement pump |
US20080319385A1 (en) * | 2007-06-25 | 2008-12-25 | Kriesel Marshall S | Fluid dispenser with additive sub-system |
US8211059B2 (en) * | 2007-06-25 | 2012-07-03 | Kriesel Marshall S | Fluid dispenser with additive sub-system |
EP2240155B1 (en) | 2008-02-13 | 2012-06-06 | Intarcia Therapeutics, Inc | Devices, formulations, and methods for delivery of multiple beneficial agents |
JP5050982B2 (en) * | 2008-04-24 | 2012-10-17 | セイコーエプソン株式会社 | Fluid ejection device and surgical scalpel |
US7959598B2 (en) | 2008-08-20 | 2011-06-14 | Asante Solutions, Inc. | Infusion pump systems and methods |
CA2740875A1 (en) * | 2008-10-15 | 2010-04-22 | Symbios Medical Products, Llc | Electronic flow control |
MX2011004086A (en) | 2008-10-16 | 2011-06-20 | Linguaflex Llc | Methods and devices for treating sleep apnea. |
US8183740B2 (en) * | 2008-12-17 | 2012-05-22 | Discovery Technology International, Inc. | Piezoelectric motor with high torque |
WO2010107739A2 (en) | 2009-03-18 | 2010-09-23 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions of treating a flaviviridae family viral infection |
US20110152770A1 (en) | 2009-07-30 | 2011-06-23 | Tandem Diabetes Care, Inc. | Infusion pump system with disposable cartridge having pressure venting and pressure feedback |
RU2547990C2 (en) | 2009-09-28 | 2015-04-10 | Интарсия Терапьютикс, Инк. | Fast achievement and/or completion of substantial stable drug delivery |
CA2778678A1 (en) | 2009-10-30 | 2011-05-05 | Cns Therapeutics, Inc. | Improved neurturin molecules |
AU2011248625B2 (en) | 2010-04-26 | 2017-01-05 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-tRNA synthetase |
AU2011248614B2 (en) | 2010-04-27 | 2017-02-16 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases |
US8993723B2 (en) | 2010-04-28 | 2015-03-31 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of alanyl-tRNA synthetases |
JP5991963B2 (en) | 2010-04-29 | 2016-09-14 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of valyl tRNA synthetase |
US9068177B2 (en) | 2010-04-29 | 2015-06-30 | Atyr Pharma, Inc | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
CN103097523B (en) | 2010-04-29 | 2016-09-28 | Atyr医药公司 | The innovation for the treatment of, diagnosis and the antibody compositions relevant to the protein fragments of Asparaginyl-tRNA synthetase finds |
JP6008840B2 (en) | 2010-05-03 | 2016-10-19 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of phenylalanyl αtRNA synthetase |
CN103140233B (en) | 2010-05-03 | 2017-04-05 | Atyr 医药公司 | Treatment, diagnosis and the discovery of antibody compositions related to the protein fragments of methionyl-tRNA synthetase |
CN103096925A (en) | 2010-05-03 | 2013-05-08 | Atyr医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-tRNA synthetases |
JP6008844B2 (en) | 2010-05-04 | 2016-10-19 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of the p38 MULTI-tRNA synthetase complex |
WO2011143482A2 (en) | 2010-05-14 | 2011-11-17 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
CA2800281C (en) | 2010-06-01 | 2021-01-12 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
CA3011688C (en) | 2010-06-09 | 2021-02-23 | Valeritas, Inc. | Fluid delivery device needle retraction mechanisms, cartridges and expandable hydraulic fluid seals |
JP6116479B2 (en) | 2010-07-12 | 2017-04-19 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of glycyl-tRNA synthetase |
US9029506B2 (en) | 2010-08-25 | 2015-05-12 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-tRNA synthetases |
US20120208755A1 (en) | 2011-02-16 | 2012-08-16 | Intarcia Therapeutics, Inc. | Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers |
WO2012175698A1 (en) | 2011-06-23 | 2012-12-27 | Université Libre de Bruxelles | Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease |
US10010667B2 (en) * | 2011-10-18 | 2018-07-03 | Medtronic, Inc. | Implantable infusion device including anti-sealing reservoir |
MY171759A (en) | 2011-12-06 | 2019-10-28 | Univ Leland Stanford Junior | Methods and compositions for treating viral diseases |
US8591456B2 (en) | 2011-12-28 | 2013-11-26 | Palyon Medical (Bvi) Limited | Multiple reservoir programmable pump |
RS65875B1 (en) | 2012-03-30 | 2024-09-30 | Insulet Corp | Fluid delivery device with transcutaneous access tool, insertion mechanism and blood glucose monitoring for use therewith |
US9180242B2 (en) | 2012-05-17 | 2015-11-10 | Tandem Diabetes Care, Inc. | Methods and devices for multiple fluid transfer |
US9173998B2 (en) | 2013-03-14 | 2015-11-03 | Tandem Diabetes Care, Inc. | System and method for detecting occlusions in an infusion pump |
US9561324B2 (en) | 2013-07-19 | 2017-02-07 | Bigfoot Biomedical, Inc. | Infusion pump system and method |
US9889085B1 (en) | 2014-09-30 | 2018-02-13 | Intarcia Therapeutics, Inc. | Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c |
ES2968262T3 (en) | 2015-06-03 | 2024-05-08 | I2O Therapeutics Inc | Implant placement systems |
US11065381B2 (en) * | 2015-10-05 | 2021-07-20 | E3D A.C.A.L. | Infusion pump device and method for use thereof |
WO2017091624A1 (en) | 2015-11-24 | 2017-06-01 | Insulet Corporation | Wearable automated medication delivery system |
WO2017091584A1 (en) | 2015-11-25 | 2017-06-01 | Insulet Corporation | Wearable medication delivery device |
EP3374905A1 (en) | 2016-01-13 | 2018-09-19 | Bigfoot Biomedical, Inc. | User interface for diabetes management system |
CN112933333B (en) | 2016-01-14 | 2023-03-28 | 比格福特生物医药公司 | Adjusting insulin delivery rate |
WO2017123703A2 (en) | 2016-01-14 | 2017-07-20 | Bigfoot Biomedical, Inc. | Occlusion resolution in medication delivery devices, systems, and methods |
TWI754643B (en) | 2016-05-16 | 2022-02-11 | 美商因塔希亞治療公司 | Glucagon-receptor selective polypeptides and methods of use thereof |
WO2017205816A1 (en) | 2016-05-26 | 2017-11-30 | Insulet Corporation | Single dose drug delivery device |
USD860451S1 (en) | 2016-06-02 | 2019-09-17 | Intarcia Therapeutics, Inc. | Implant removal tool |
USD840030S1 (en) | 2016-06-02 | 2019-02-05 | Intarcia Therapeutics, Inc. | Implant placement guide |
AT518714B1 (en) | 2016-06-03 | 2018-09-15 | Ami Agency Medical Innovations Gmbh | Medical device for narrowing or shutting off a body canal |
AT518411B1 (en) | 2016-06-14 | 2017-10-15 | Ami Agency Medical Innovations Gmbh | Medical device for shutting off a body canal |
AT518764B1 (en) | 2016-06-14 | 2018-03-15 | Ami Agency Medical Innovations Gmbh | Medical device for shutting off a body canal |
US10363372B2 (en) | 2016-08-12 | 2019-07-30 | Insulet Corporation | Plunger for drug delivery device |
WO2018035032A1 (en) | 2016-08-14 | 2018-02-22 | Insulet Corporation | Automatic drug delivery device with trigger mechanism |
US10751478B2 (en) | 2016-10-07 | 2020-08-25 | Insulet Corporation | Multi-stage delivery system |
US10780217B2 (en) | 2016-11-10 | 2020-09-22 | Insulet Corporation | Ratchet drive for on body delivery system |
CA3037432A1 (en) | 2016-12-12 | 2018-06-21 | Bigfoot Biomedical, Inc. | Alarms and alerts for medication delivery devices and related systems and methods |
EP3554388A4 (en) | 2016-12-13 | 2020-08-12 | Linguaflex, Inc. | Tongue retractor |
KR20190104039A (en) | 2017-01-03 | 2019-09-05 | 인타르시아 세라퓨틱스 인코포레이티드 | Methods Including Continuous Administration of GLP-1 Receptor Agonists and Co-administration of Drugs |
EP3568859A1 (en) | 2017-01-13 | 2019-11-20 | Bigfoot Biomedical, Inc. | Insulin delivery methods, systems and devices |
US10881793B2 (en) | 2017-01-13 | 2021-01-05 | Bigfoot Biomedical, Inc. | System and method for adjusting insulin delivery |
WO2018136699A1 (en) | 2017-01-19 | 2018-07-26 | Insulet Corporation | Cartridge hold-up volume reduction |
WO2018156548A1 (en) | 2017-02-22 | 2018-08-30 | Insulet Corporation | Needle insertion mechanisms for drug containers |
US10695485B2 (en) | 2017-03-07 | 2020-06-30 | Insulet Corporation | Very high volume user filled drug delivery device |
US10106393B1 (en) | 2017-04-19 | 2018-10-23 | Winter Creek Designs | Beverage dispensing system |
WO2019028342A1 (en) | 2017-08-03 | 2019-02-07 | Insulet Corporation | Micro piston pump |
US10973978B2 (en) | 2017-08-03 | 2021-04-13 | Insulet Corporation | Fluid flow regulation arrangements for drug delivery devices |
US11786668B2 (en) | 2017-09-25 | 2023-10-17 | Insulet Corporation | Drug delivery devices, systems, and methods with force transfer elements |
US10898656B2 (en) | 2017-09-26 | 2021-01-26 | Insulet Corporation | Needle mechanism module for drug delivery device |
US11147931B2 (en) | 2017-11-17 | 2021-10-19 | Insulet Corporation | Drug delivery device with air and backflow elimination |
USD928199S1 (en) | 2018-04-02 | 2021-08-17 | Bigfoot Biomedical, Inc. | Medication delivery device with icons |
US10874803B2 (en) | 2018-05-31 | 2020-12-29 | Insulet Corporation | Drug cartridge with drive system |
EP3801682A1 (en) | 2018-06-06 | 2021-04-14 | Insulet Corporation | Linear shuttle pump for drug delivery |
USD933219S1 (en) | 2018-07-13 | 2021-10-12 | Intarcia Therapeutics, Inc. | Implant removal tool and assembly |
CA3117989C (en) | 2018-11-28 | 2024-02-20 | Insulet Corporation | Drug delivery shuttle pump system and valve assembly |
USD920343S1 (en) | 2019-01-09 | 2021-05-25 | Bigfoot Biomedical, Inc. | Display screen or portion thereof with graphical user interface associated with insulin delivery |
US11369735B2 (en) | 2019-11-05 | 2022-06-28 | Insulet Corporation | Component positioning of a linear shuttle pump |
KR20220140711A (en) | 2020-01-13 | 2022-10-18 | 듀렉트 코퍼레이션 | Reduced Impurity Sustained Release Drug Delivery Systems and Related Methods |
CN111636980B (en) * | 2020-05-15 | 2021-06-18 | 大连理工大学 | Bellows type storage tank for liquid propellant |
RU201295U1 (en) * | 2020-09-07 | 2020-12-08 | Российская Федерация, от имени которой выступает ФОНД ПЕРСПЕКТИВНЫХ ИССЛЕДОВАНИЙ | Adjustable bellows displacer |
RU201296U1 (en) * | 2020-09-16 | 2020-12-08 | Российская Федерация, от имени которой выступает ФОНД ПЕРСПЕКТИВНЫХ ИССЛЕДОВАНИЙ | Double-circuit bellows hydraulic displacer |
WO2024147928A1 (en) | 2023-01-06 | 2024-07-11 | Insulet Corporation | Automatically or manually initiated meal bolus delivery with subsequent automatic safety constraint relaxation |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2972991A (en) * | 1958-10-01 | 1961-02-28 | Burron Medical Prod Inc | Disposable syringe |
GB1223591A (en) * | 1968-03-22 | 1971-02-24 | English Electric Co Ltd | Improvements in or relating to pumps |
DE2355966A1 (en) * | 1973-11-09 | 1975-05-22 | Medac Klinische Spezialpraep | PUMP ARRANGEMENT, ESPECIALLY FOR BLOOD PUMPS |
BR7806153A (en) * | 1978-09-19 | 1980-04-01 | Halen Elliot Brasil Ind Com Eq | HYPODERMIC PRESSURE INJECTOR FOR INTERMITTENT VACCINATION |
US4265241A (en) * | 1979-02-28 | 1981-05-05 | Andros Incorporated | Implantable infusion device |
US4351335A (en) * | 1979-04-16 | 1982-09-28 | Whitney Douglass G | Injection device and method |
US4457752A (en) * | 1982-09-13 | 1984-07-03 | Csaba Vadasz | Surgically implantable pump |
US4581018A (en) * | 1983-02-08 | 1986-04-08 | Novacor Medical Corporation | Implantable infusion device |
EP0168675B1 (en) * | 1984-06-21 | 1990-04-11 | David R. Fischell | Finger actuated medication infusion system |
US4626243A (en) * | 1985-06-21 | 1986-12-02 | Applied Biomedical Corporation | Gravity-independent infusion system |
FR2618681A1 (en) * | 1987-07-31 | 1989-02-03 | Spiral | METHOD AND DEVICE FOR ADMINISTRATION USEFUL IN PARTICULAR IN THE FIELD OF INFUSION |
DE4039191C1 (en) * | 1990-12-08 | 1991-11-07 | B. Braun Melsungen Ag, 3508 Melsungen, De | Liq. drug infusion pump - has rigid housing contg. drug chamber with volume varied by piston like ejector acting with spring unit |
TW279133B (en) * | 1990-12-13 | 1996-06-21 | Elan Med Tech | |
US5176641A (en) * | 1991-07-08 | 1993-01-05 | Infusaid, Inc. | Implantable drug infusion reservoir having fluid impelling resilient foam member |
US5980489A (en) * | 1992-04-17 | 1999-11-09 | Science Incorporated | Fluid dispenser with fill adapter |
CA2083555A1 (en) * | 1992-11-23 | 1994-05-24 | David H. Laing | Portable infusion device |
US5476449A (en) * | 1992-12-28 | 1995-12-19 | Richmond; Frank M. | Needleless multi-liquid medicament delivery system with membranes |
US5290240A (en) * | 1993-02-03 | 1994-03-01 | Pharmetrix Corporation | Electrochemical controlled dispensing assembly and method for selective and controlled delivery of a dispensing fluid |
US5348539A (en) * | 1993-06-29 | 1994-09-20 | Glenn Herskowitz | Infusion pump for use with prepackaged IV bags |
SE9400821D0 (en) * | 1994-03-10 | 1994-03-10 | Siemens Elema Ab | Implantable infusion system with pressure neutral drug container |
US5514103A (en) * | 1994-06-14 | 1996-05-07 | Minimed Inc. | Medication infusion pump with improved pressure reservoir |
DE4432991C1 (en) * | 1994-09-16 | 1995-10-26 | Fresenius Ag | Infusion pump for dispensing medicines into human body |
DE19517291C2 (en) * | 1995-05-11 | 1997-05-15 | Fresenius Ag | Method for filling a propellant space of a gas pressure-operated medication pump and gas pressure-operated medication pump |
US5700245A (en) * | 1995-07-13 | 1997-12-23 | Winfield Medical | Apparatus for the generation of gas pressure for controlled fluid delivery |
KR100373772B1 (en) * | 1995-07-31 | 2003-09-13 | 심영택 | Treatment apparatus for erectile disorder |
US5807335A (en) * | 1995-12-22 | 1998-09-15 | Science Incorporated | Fluid delivery device with conformable ullage and fill assembly |
US5830187A (en) * | 1995-12-22 | 1998-11-03 | Science Incorporated | Fluid delivery device with conformable ullage and fill assembly |
US5976109A (en) | 1996-04-30 | 1999-11-02 | Medtronic, Inc. | Apparatus for drug infusion implanted within a living body |
US5785688A (en) * | 1996-05-07 | 1998-07-28 | Ceramatec, Inc. | Fluid delivery apparatus and method |
JP3208759B2 (en) * | 1997-03-18 | 2001-09-17 | ニプロ株式会社 | Chemical self-injection tool |
-
1996
- 1996-04-30 US US08/641,362 patent/US5976109A/en not_active Expired - Lifetime
-
1999
- 1999-10-11 US US09/416,151 patent/US6394981B2/en not_active Expired - Fee Related
- 1999-10-11 US US09/415,809 patent/US6190359B1/en not_active Expired - Fee Related
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090060987A1 (en) * | 2002-11-26 | 2009-03-05 | Kaemmerer William F | Devices, systems and methods for improving memory and/or cognitive function through brain delivery of sirna |
US8618069B2 (en) | 2002-11-26 | 2013-12-31 | Medtronic, Inc. | Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA |
US7829694B2 (en) | 2002-11-26 | 2010-11-09 | Medtronic, Inc. | Treatment of neurodegenerative disease through intracranial delivery of siRNA |
US7618948B2 (en) | 2002-11-26 | 2009-11-17 | Medtronic, Inc. | Devices, systems and methods for improving and/or cognitive function through brain delivery of siRNA |
US8119611B2 (en) | 2002-11-26 | 2012-02-21 | Medtronic, Inc. | Treatment of neurodegenerative disease through intracranial delivery of SIRNA |
US7605249B2 (en) | 2002-11-26 | 2009-10-20 | Medtronic, Inc. | Treatment of neurodegenerative disease through intracranial delivery of siRNA |
US8058251B2 (en) | 2002-11-26 | 2011-11-15 | Kaemmerer William F | Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA |
US8415319B2 (en) | 2002-11-26 | 2013-04-09 | Medtronic, Inc. | Devices, systems and methods for improving memory and/or cognitive function through brain delivery of siRNA |
US8957198B2 (en) | 2003-02-03 | 2015-02-17 | Medtronic, Inc. | Compositions, devices and methods for treatment of Huntington's disease through intracranial delivery of sirna |
US7732591B2 (en) | 2003-11-25 | 2010-06-08 | Medtronic, Inc. | Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
US20070167389A1 (en) * | 2003-11-25 | 2007-07-19 | Kaemmerer William F | Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
US20110213328A1 (en) * | 2004-03-18 | 2011-09-01 | Medtronic, Inc. | Methods and Systems for Treatment of Neurological Diseases of the Central Nervous System |
EP1600120A1 (en) * | 2004-05-28 | 2005-11-30 | Ethicon Endo-Surgery, Inc. | Metal bellows position feedback for hydraulic control of an adjustable gastric band |
US7250039B2 (en) * | 2004-07-15 | 2007-07-31 | P. Rowan Smith, Jr. | Compression bulb hypodermic syringe |
US20060084926A1 (en) * | 2004-07-15 | 2006-04-20 | P. Rowan Smith, Jr. | Compression bulb hypodermic syring |
US20060253068A1 (en) * | 2005-04-20 | 2006-11-09 | Van Bilsen Paul | Use of biocompatible in-situ matrices for delivery of therapeutic cells to the heart |
US20100325746A9 (en) * | 2005-05-06 | 2010-12-23 | Kaemmerer William F | Methods and sequences to suppress primate huntington gene expression in vivo |
US20100008981A1 (en) * | 2005-05-06 | 2010-01-14 | Medtronic, Inc. | Methods and sequences to suppress primate huntington gene expression |
US7902352B2 (en) | 2005-05-06 | 2011-03-08 | Medtronic, Inc. | Isolated nucleic acid duplex for reducing huntington gene expression |
US20070261126A1 (en) * | 2005-05-06 | 2007-11-08 | Kaemmerer William F | Methods and sequences to suppress primate huntington gene expression in vivo |
US8258112B2 (en) | 2005-05-06 | 2012-09-04 | Medtronic, Inc | Methods and sequences to suppress primate huntington gene Expression |
US9133517B2 (en) | 2005-06-28 | 2015-09-15 | Medtronics, Inc. | Methods and sequences to preferentially suppress expression of mutated huntingtin |
US20080280843A1 (en) * | 2006-05-24 | 2008-11-13 | Van Bilsen Paul | Methods and kits for linking polymorphic sequences to expanded repeat mutations |
US9273356B2 (en) | 2006-05-24 | 2016-03-01 | Medtronic, Inc. | Methods and kits for linking polymorphic sequences to expanded repeat mutations |
US20080039415A1 (en) * | 2006-08-11 | 2008-02-14 | Gregory Robert Stewart | Retrograde transport of sirna and therapeutic uses to treat neurologic disorders |
US8324367B2 (en) | 2006-11-03 | 2012-12-04 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
US9375440B2 (en) | 2006-11-03 | 2016-06-28 | Medtronic, Inc. | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
US20080124379A1 (en) * | 2006-11-03 | 2008-05-29 | Kaemmerer William F | Compositions and methods for making therapies delivered by viral vectors reversible for safety and allele-specificity |
US7988668B2 (en) | 2006-11-21 | 2011-08-02 | Medtronic, Inc. | Microsyringe for pre-packaged delivery of pharmaceuticals |
WO2008064073A3 (en) * | 2006-11-21 | 2008-07-31 | Medtronic Inc | Microsyringe for pre-packaged delivery of pharmaceuticals |
US7819842B2 (en) | 2006-11-21 | 2010-10-26 | Medtronic, Inc. | Chronically implantable guide tube for repeated intermittent delivery of materials or fluids to targeted tissue sites |
US20080119787A1 (en) * | 2006-11-21 | 2008-05-22 | Kaemmerer William F | Microsyringe for pre-packaged delivery of pharmaceuticals |
US20080171906A1 (en) * | 2007-01-16 | 2008-07-17 | Everaerts Frank J L | Tissue performance via hydrolysis and cross-linking |
US9694165B2 (en) * | 2008-01-28 | 2017-07-04 | Peter Mats Forsell | Implantable drainage device |
US8961448B2 (en) * | 2008-01-28 | 2015-02-24 | Peter Forsell | Implantable drainage device |
US20150157836A1 (en) * | 2008-01-28 | 2015-06-11 | Peter Mats Forsell | Implantable drainage device |
US20100312164A1 (en) * | 2008-01-28 | 2010-12-09 | Peter Forsell | Implantable drainage device |
KR101030391B1 (en) | 2009-05-22 | 2011-04-20 | 국립암센터 | Drug reservoir for intrathecal drug infusion device |
US10687676B2 (en) * | 2017-06-09 | 2020-06-23 | Hamilton Sundstrand Corporation | Microgravity urine collection and storage |
WO2019038751A1 (en) * | 2017-08-22 | 2019-02-28 | Steadymed, Ltd | Selectively mechanically activatable prefilled infusion-pump devices |
CN111356489A (en) * | 2017-08-22 | 2020-06-30 | 斯泰迪麦德有限公司 | Pre-filled infusion pump device capable of being selectively mechanically actuated |
CN110141720A (en) * | 2019-06-21 | 2019-08-20 | 青岛大学附属医院 | A kind of operating room transfusion bags heat-insulating pressurizing device |
EP4056210A1 (en) * | 2021-03-12 | 2022-09-14 | Insulet Corporation | Pumping mechanism with wire-pulled plunger |
Also Published As
Publication number | Publication date |
---|---|
US6394981B2 (en) | 2002-05-28 |
US5976109A (en) | 1999-11-02 |
US6190359B1 (en) | 2001-02-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6190359B1 (en) | Method and apparatus for drug infusion | |
US11229741B2 (en) | Fluid delivery device, transcutaneous access tool and fluid drive mechanism for use therewith | |
EP1512422B1 (en) | Implantable pump with adjustable flow rate | |
EP2263719B1 (en) | Multireservoir implantable drug delivery pumps | |
EP0344895B1 (en) | Constant pressure variable flow implantable pump | |
US4718893A (en) | Pressure regulated implantable infusion pump | |
US5607418A (en) | Implantable drug delivery apparatus | |
US4772263A (en) | Spring driven infusion pump | |
US6629954B1 (en) | Drug delivery pump with isolated hydraulic metering | |
JPH0151268B2 (en) | ||
WO1987004631A1 (en) | Spring driven infusion pump | |
US20140214010A1 (en) | Drug delivery device with compressible fluid chambers | |
US5135497A (en) | Large volume pressurized fluid dispenser | |
US9259530B2 (en) | Implantable infusion device | |
CN218220736U (en) | Positive displacement pump and fluid delivery system | |
EP0245056A1 (en) | Ambulatory disposable infusion pump |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
REMI | Maintenance fee reminder mailed | ||
LAPS | Lapse for failure to pay maintenance fees | ||
STCH | Information on status: patent discontinuation |
Free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
|
FP | Lapsed due to failure to pay maintenance fee |
Effective date: 20140528 |